1)Akao M, et al:Current status of clinical background of patients with atrial fibrillation in a community-based survey;The Fushimi AF Registry. J Cardiol 61:260-266, 2013
2)Takabayashi K, et al:Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation;The fushimi atrial fibrillation registry. Stroke 46:3354-3361, 2015
3)Kato T, et al:Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ J 68:568-572, 2004
4)Ogawa H, et al:Progression from paroxysmal to sustained atrial fibrillation is associated with increased adverse events. Stroke 48:2301-2308, 2018
5)Wynn GJ, et al:The European Heart Rhythm Association symptom classification for atrial fibrillation;Validation and improvement through a simple modification. Europace 16:965-972, 2014
6)Ogawa S, et al:Optimal treatment strategy for patients with paroxysmal atrial fibrillation;J-RHYTHM Study. Circ J 73:242-248, 2009
7)Al-Khatib SM, et al:Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation;Results from the ARISTOTLE trial. Eur Heart J 34:2464-2471, 2013
8)Esato M, et al:Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation. Chest 6:1266-1275, 2017
9)出口一郎,他:心房細動(発作性と持続性)における重症度,予後等の相違.小林祥泰(編):脳卒中データバンク2015,pp 58-59,中山書店,2015
10)Boriani G, et al:Device-detected atrial fibrillation and risk for stroke;An analysis of >10, 000 patients from the SOS AF project. Eur Heart J 35:508-516, 2014